BioCentury | Apr 22, 2021
Management Tracks

Ceesay joins Coles’ Cerevel as president; plus updates from Replimune, Perceptive, Antiva, Vera, Patient Square, Zymeworks and more

...Inc. hired Chris Aiello as head of Canada and general manager. Aiello joins from Sanofi Genzyme...
BioCentury | Apr 21, 2021
Finance

With upsized opportunity fund closing at €360M, Forbion readies to build on portfolio with three-pronged strategy

...Karpova, formerly of boutique life sciences bank Kempen; Carlo Incerti, a former CMO at the Genzyme...
BioCentury | Mar 31, 2021
Emerging Company Profile

Mega-round meets dealmaker as CBC’s AffaMed readies to build pipeline

...of Japan and Asia Pacific R&D for Genzyme Corp....
BioCentury | Feb 26, 2021
Management Tracks

Ziopharm CEO stepping down; plus moves at ChemoCentryx, ReForm, Monte Rosa and Enterin

...therapy avacopan.Protein therapeutics company ReForm Biologics appointed James Sherblom as chairman. Sherblom was the founding CFO of Genzyme Corp....
BioCentury | Feb 13, 2021
Deals

Feb. 12 Quick Takes: NexImmune, Decibel rise in NASDAQ debuts; plus Sagimet’s $80M crossover, Forbion launches VectorY, Aurora Science leads InteRNA round and a SPAC for Sharecare

...establish its own GMP manufacturing facilities. Forbion Operating Partner Carlo Incerti, a former CMO of Sanofi Genzyme...
BioCentury | Jan 29, 2021
Management Tracks

Kirk Raab, first BIO chair and early Genentech CEO, dies at 85

...growth hormone.” He noted that Henri Termeer’s Genzyme Corp....
...as is his current company.Indeed, Raab said Genzyme...
BioCentury | Jan 12, 2021
Emerging Company Profile

Atalanta’s next-gen RNAi branches deeper into brain, hooks Biogen and Genentech

...her 15 year tenure at rare disease-focused Genzyme Corp....
...Biosciences Inc., Moderna Inc. (NASDAQ:MRNA) and the Genzyme...
BioCentury | Dec 19, 2020
Management Tracks

RNA pioneer Crooke readies to look beyond Ionis

...founding CEO of Amgen Inc. (NASDAQ:AMGN); Leonard Schleifer, founder, president and CEO of Regeneron Pharmaceuticals Inc. (NASDAQ:REGN); and Genzyme Corp.’s...
BioCentury | Dec 4, 2020
Product Development

Continuing the conversation with Henri: Termeer Square dedicated

...the site of the one-time headquarters of Genzyme Corp....
...by life sciences companies and their leaders. Steve Usdin Genzyme Corp. Sanofi Alnylam...
BioCentury | Oct 2, 2020
Deals

From Termeer to scuttled Allergan deal, Lysosomal’s winding road continues with Bial takeout

...CEO of Bial Biotech, and three former Genzyme Corp....
Items per page:
1 - 10 of 3631
BioCentury | Apr 22, 2021
Management Tracks

Ceesay joins Coles’ Cerevel as president; plus updates from Replimune, Perceptive, Antiva, Vera, Patient Square, Zymeworks and more

...Inc. hired Chris Aiello as head of Canada and general manager. Aiello joins from Sanofi Genzyme...
BioCentury | Apr 21, 2021
Finance

With upsized opportunity fund closing at €360M, Forbion readies to build on portfolio with three-pronged strategy

...Karpova, formerly of boutique life sciences bank Kempen; Carlo Incerti, a former CMO at the Genzyme...
BioCentury | Mar 31, 2021
Emerging Company Profile

Mega-round meets dealmaker as CBC’s AffaMed readies to build pipeline

...of Japan and Asia Pacific R&D for Genzyme Corp....
BioCentury | Feb 26, 2021
Management Tracks

Ziopharm CEO stepping down; plus moves at ChemoCentryx, ReForm, Monte Rosa and Enterin

...therapy avacopan.Protein therapeutics company ReForm Biologics appointed James Sherblom as chairman. Sherblom was the founding CFO of Genzyme Corp....
BioCentury | Feb 13, 2021
Deals

Feb. 12 Quick Takes: NexImmune, Decibel rise in NASDAQ debuts; plus Sagimet’s $80M crossover, Forbion launches VectorY, Aurora Science leads InteRNA round and a SPAC for Sharecare

...establish its own GMP manufacturing facilities. Forbion Operating Partner Carlo Incerti, a former CMO of Sanofi Genzyme...
BioCentury | Jan 29, 2021
Management Tracks

Kirk Raab, first BIO chair and early Genentech CEO, dies at 85

...growth hormone.” He noted that Henri Termeer’s Genzyme Corp....
...as is his current company.Indeed, Raab said Genzyme...
BioCentury | Jan 12, 2021
Emerging Company Profile

Atalanta’s next-gen RNAi branches deeper into brain, hooks Biogen and Genentech

...her 15 year tenure at rare disease-focused Genzyme Corp....
...Biosciences Inc., Moderna Inc. (NASDAQ:MRNA) and the Genzyme...
BioCentury | Dec 19, 2020
Management Tracks

RNA pioneer Crooke readies to look beyond Ionis

...founding CEO of Amgen Inc. (NASDAQ:AMGN); Leonard Schleifer, founder, president and CEO of Regeneron Pharmaceuticals Inc. (NASDAQ:REGN); and Genzyme Corp.’s...
BioCentury | Dec 4, 2020
Product Development

Continuing the conversation with Henri: Termeer Square dedicated

...the site of the one-time headquarters of Genzyme Corp....
...by life sciences companies and their leaders. Steve Usdin Genzyme Corp. Sanofi Alnylam...
BioCentury | Oct 2, 2020
Deals

From Termeer to scuttled Allergan deal, Lysosomal’s winding road continues with Bial takeout

...CEO of Bial Biotech, and three former Genzyme Corp....
Items per page:
1 - 10 of 3631